Skip to main content
Premium Trial:

Request an Annual Quote

NCI Extends License for Partek Genomics Suite

NEW YORK (GenomeWeb News) - The National Cancer Institute has renewed its site license for Partek’s Genomics Suite software, Partek said today.
 
NCI initially licensed the statistical and visual analysis package last September.
 
The software may be used to display alternative splice events, exon-level and copy number alteration, mapping sites of protein and DNA interaction, and has import and annotation capabilities for two-color arrays, Partek said.
 
Financial terms of the agreement were not released.
The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.